The evidence that NICE looked at for ultrasound‑guided percutaneous radiofrequency ablation to treat thyroid nodules showed that the procedure was safe enough and worked well enough to be used in the ...
NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company dedicated to transforming the surgical diagnosis and treatment of neurological ...
When NICE looked at the evidence, it decided that there are no major safety concerns and there is short-term evidence that it works. The evidence for whether it works in the long term is not as strong ...
Please provide your email address to receive an email when new articles are posted on . Radiofrequency ablation reduced tumor size in patients with papillary thyroid carcinoma at 12 months. Ablation ...
Discover how radiofrequency ablation offers long-term pain relief for chronic sufferers, bridging the gap between temporary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results